Drug Profile
Grazoprevir/ruzasvir/uprifosbuvir - Merck & Co
Alternative Names: Grazoprevir/MK-3682/MK-8408; Grazoprevir/MK-3682/ruzasvir; Grazoprevir/ruzasvir/MK-3682; Grazoprevir/uprifosbuvir/ruzasvir; MK-3682/grazoprevir/ruzasvir; MK-3682/ruzasvir/grazoprevir; MK-3682B; MK-5172/MK-3682/MK-8408; MK3; Ruzasvir/grazoprevir/MK-3682; Ruzasvir/grazoprevir/uprifosbuvir; Ruzasvir/MK-3682/grazoprevir; Ruzasvir/uprifosbuvir/grazoprevir; Uprifosbuvir/grazoprevir/ruzasvir; Uprifosbuvir/ruzasvir/grazoprevirLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Antivirals; Benzoxazines; Cyclopropanes; Imidazoles; Indoles; Macrocyclic compounds; Pyrimidines; Pyrrolidines; Quinoxalines; Small molecules; Thiazoles; Uracil nucleotides
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors; Hepatitis C virus NS3 protein inhibitors; Hepatitis C virus NS4 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis C